Simple quiz may reveal hidden brain struggles in sickle cell patients

NCT ID NCT05347043

Completed Diagnosis Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether the Montreal Cognitive Assessment (MoCA), a short test, can accurately screen for thinking and memory problems in adults with sickle cell disease. Researchers compared MoCA results to a full set of standard cognitive tests in 65 adults. The goal is to find a faster way to identify patients who need further evaluation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could provide a quick, simple screening tool to detect cognitive problems in adults with sickle cell disease, enabling earlier support.
What could go wrong: This is a small, completed study (65 people) that only tests the screening tool's accuracy, not a treatment. The MoCA may not catch all cognitive issues, and results may not apply to everyone with sickle cell disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SICKLE CELL ANEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

allergic disease Cognitive Dysfunction sickle cell disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SICKLE CELL ANEMIA

Contacts and locations

Locations

Internal Medicine Department - Tenon

Paris, 75020, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.